SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-12-001458
Filing Date
2012-01-10
Accepted
2012-01-10 06:07:10
Documents
5
Period of Report
2012-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v245007_8ka.htm 8-K/A 23854
2 EXHIBIT 10.1 v245007_ex10-1.htm EX-10.1 2773
3 GRAPHIC v245007_10-1x1x1.jpg GRAPHIC 115646
4 GRAPHIC v245007_10-1x2x1.jpg GRAPHIC 53644
5 GRAPHIC v245007_10-1x3x1.jpg GRAPHIC 115930
  Complete submission text file 0001144204-12-001458.txt   421309
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-53127 | Film No.: 12518685
SIC: 4731 Arrangement of Transportation of Freight & Cargo